Literature DB >> 22734809

Future perspectives of Chinese medical formulae: chinmedomics as an effector.

Xijun Wang1, Aihua Zhang, Hui Sun.   

Abstract

Traditional Chinese medicine (TCM) has been used for thousands of years to treat or prevent disease. The health care paradigm has shifted from a focus on disease to TCM therapy with a holistic approach. However, the actual value of TCM has not been fully recognized worldwide due to a lack of scientific approaches to its study. Today omics has become practically available, and resembles TCM in many aspects, and can serve as a key driving force for the translation of the traditional Chinese medical formulae (chinmediformulae) into practice, and will develop and advance the concept of the metabolomics of chinmediformulae (chinmedomics). Chinmedomics seeks to elucidate the therapeutic and synergistic properties and metabolism of chinmediformulae and the involved metabolic pathways using modern analytical techniques. It is an integral part of top-down systems biology, which aims to improve understanding of chinmediformulae. This approach of combining chinmedomics with chinmediformulae with modern health care systems may lead to a revolution in TCM therapy. Although the scientific study of chinmedomics is at an early stage and requires further scrutiny and validation, the approach has major implications to improve the efficacy of chinmediformulae. This article introduces and reviews the concept of chinmedomics, and highlights recent examples of the approach, which are presented for description and discussion.

Mesh:

Substances:

Year:  2012        PMID: 22734809      PMCID: PMC3394855          DOI: 10.1089/omi.2011.0138

Source DB:  PubMed          Journal:  OMICS        ISSN: 1536-2310


  53 in total

1.  Metabolomic study of insomnia and intervention effects of Suanzaoren decoction using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry.

Authors:  Bo Yang; Aihua Zhang; Hui Sun; Wei Dong; Guangli Yan; Tingli Li; Xijun Wang
Journal:  J Pharm Biomed Anal       Date:  2011-10-04       Impact factor: 3.935

Review 2.  Modern analytical techniques in metabolomics analysis.

Authors:  Aihua Zhang; Hui Sun; Ping Wang; Ying Han; Xijun Wang
Journal:  Analyst       Date:  2011-11-21       Impact factor: 4.616

3.  An in vivo analysis of the therapeutic and synergistic properties of Chinese medicinal formula Yin-Chen-Hao-Tang based on its active constituents.

Authors:  Aihua Zhang; Hui Sun; Ye Yuan; Wenjun Sun; Guozheng Jiao; Xijun Wang
Journal:  Fitoterapia       Date:  2011-07-29       Impact factor: 2.882

4.  [A metabonomic study on the treatment of diabetic nephropathy with traditional Chinese medicine tang-shen-fang].

Authors:  Huan Yu; Li Li; Qionglin Liang; Yiming Wang; Ping Li; Guoan Luo
Journal:  Se Pu       Date:  2011-04

5.  Metabolomics study on Fuzi and its processed products using ultra-performance liquid-chromatography/electrospray-ionization synapt high-definition mass spectrometry coupled with pattern recognition analysis.

Authors:  Hui Sun; Bei Ni; Aihua Zhang; Mo Wang; Hui Dong; Xijun Wang
Journal:  Analyst       Date:  2011-10-26       Impact factor: 4.616

6.  UPLC-MS-based urine metabolomics reveals indole-3-lactic acid and phenyllactic acid as conserved biomarkers for alcohol-induced liver disease in the Ppara-null mouse model.

Authors:  Soumen K Manna; Andrew D Patterson; Qian Yang; Kristopher W Krausz; Jeffrey R Idle; Albert J Fornace; Frank J Gonzalez
Journal:  J Proteome Res       Date:  2011-07-28       Impact factor: 4.466

7.  Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry.

Authors:  Xiaoxia Gao; Xingyu Zheng; Zhenyu Li; Yuzhi Zhou; Haifeng Sun; Lizeng Zhang; Xiaoqing Guo; Guanhua Du; Xuemei Qin
Journal:  J Ethnopharmacol       Date:  2011-06-21       Impact factor: 4.360

8.  Combination therapy utilizing shRNA knockdown and an optimized resistant transgene for rescue of diseases caused by misfolded proteins.

Authors:  Chengwen Li; Pingjie Xiao; Steven James Gray; Marc Scott Weinberg; R Jude Samulski
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

9.  Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.

Authors:  Ena Wang; Scott Bussom; Jinguo Chen; Courtney Quinn; Davide Bedognetti; Wing Lam; Fulan Guan; Zaoli Jiang; Yichao Mark; Yingdong Zhao; David F Stroncek; Jeffrey White; Francesco M Marincola; Yung-Chi Cheng
Journal:  BMC Med Genomics       Date:  2011-05-11       Impact factor: 3.063

10.  Potential biomarkers in mouse myocardium of doxorubicin-induced cardiomyopathy: a metabonomic method and its application.

Authors:  Guangguo Tan; Ziyang Lou; Wenting Liao; Zhenyu Zhu; Xin Dong; Wei Zhang; Wuhong Li; Yifeng Chai
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

View more
  35 in total

1.  Clinical efficacy of 'Spleen-kidney-care' Yiqi Huayu and Jiangzhuo traditional Chinese medicine for the treatment of patients with diabetic nephropathy.

Authors:  Hong Liu; Jin Zheng; Rong-Heng Li
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

Review 2.  Cell metabolomics.

Authors:  Aihua Zhang; Hui Sun; Hongying Xu; Shi Qiu; Xijun Wang
Journal:  OMICS       Date:  2013-08-29

3.  Metabolomics study of type 2 diabetes using ultra-performance LC-ESI/quadrupole-TOF high-definition MS coupled with pattern recognition methods.

Authors:  Ai-hua Zhang; Hui Sun; Guang-li Yan; Ye Yuan; Ying Han; Xi-jun Wang
Journal:  J Physiol Biochem       Date:  2013-08-24       Impact factor: 4.158

4.  Convergent Lines of Descent: Symptoms, Patterns, Constellations, and the Emergent Interface of Systems Biology and Chinese Medicine.

Authors:  Volker Scheid
Journal:  East Asian Sci Technol Soc       Date:  2014-03-01

5.  Berberine ameliorates nonbacterial prostatitis via multi-target metabolic network regulation.

Authors:  Hui Sun; Huiyu Wang; Aihua Zhang; Guangli Yan; Yue Zhang; Na An; Xijun Wang
Journal:  OMICS       Date:  2015-01-14

Review 6.  Metabolomics insights into pathophysiological mechanisms of nephrology.

Authors:  Aihua Zhang; Hui Sun; Shi Qiu; Xijun Wang
Journal:  Int Urol Nephrol       Date:  2013-11-12       Impact factor: 2.370

7.  Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies.

Authors:  Xijun Wang; Aihua Zhang; Ping Wang; Hui Sun; Gelin Wu; Wenjun Sun; Haitao Lv; Guozheng Jiao; Hongying Xu; Ye Yuan; Lian Liu; Dixin Zou; Zeming Wu; Ying Han; Guangli Yan; Wei Dong; Fangfang Wu; Tianwei Dong; Yang Yu; Shuxiang Zhang; Xiuhong Wu; Xin Tong; Xiangcai Meng
Journal:  Mol Cell Proteomics       Date:  2013-01-29       Impact factor: 5.911

8.  Metabolomic analysis of key regulatory metabolites in hepatitis C virus-infected tree shrews.

Authors:  Hui Sun; Aihua Zhang; Guangli Yan; Chengyu Piao; Weiyun Li; Chang Sun; Xiuhong Wu; Xinghua Li; Yun Chen; Xijun Wang
Journal:  Mol Cell Proteomics       Date:  2012-12-20       Impact factor: 5.911

9.  Dissection of Biological Property of Chinese Acupuncture Point Zusanli Based on Long-Term Treatment via Modulating Multiple Metabolic Pathways.

Authors:  Guangli Yan; Aihua Zhang; Hui Sun; Weiping Cheng; Xiangcai Meng; Li Liu; Yingzhi Zhang; Ning Xie; Xijun Wang
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-01       Impact factor: 2.629

10.  Urinary metabolic biomarker and pathway study of hepatitis B virus infected patients based on UPLC-MS system.

Authors:  Aihua Zhang; Hui Sun; Ying Han; Guangli Yan; Xijun Wang
Journal:  PLoS One       Date:  2013-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.